Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand

Budesonide/Formoterol for Maintenance and Reliever Therapy: A Medication Use Evaluation Among Persistent Asthma Patients in General Practice in Thailand

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00800241

Enrollment

1020

Registered

2008-12-02

Start date

2009-05-31

Completion date

2009-11-30

Last updated

2010-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, Symbicort SMART, Thai patient eligibility, Persistent asthma

Brief summary

The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

12 Years to No maximum

Healthy volunteers

Inclusion criteria

* Established persistent asthma * Currently treated with Symbicort SMART for 3 months or longer

Exclusion criteria

* currently participating or have participated in a study with an investigational compound within the last 30 days * current diagnosis of chronic obstructive pulmonary disease (COPD) * smoked more than 10 pack-year

Design outcomes

Primary

Measure	Time frame
Number of budesonide/formoterol use per patient	On the survey date

Countries

Thailand

Outcome results